Conference
PRM34 Why are the findings of cost-effectiveness analyses of biologic treatment for rheumatoid arthritis so different?
Authors
Druyts E; Thorlund K; Mills E
Volume
16
Publisher
Elsevier
Publication Date
May 2013
DOI
10.1016/j.jval.2013.03.112
Conference proceedings
Value in Health
Issue
3
ISSN
1098-3015